GNOMvsIVV
Global X Genomics & Biotechnology ETF against iShares Core S&P 500 ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| GNOM | IVV | |
|---|---|---|
| Expense ratio | 0.50% | 0.030% |
| Assets | $85M | $889.4B |
| Net flow, 1 month | — | −$6.7B |
| Net flow, 1 year | — | +$97.3B |
| Return, YTD | +46.2% | +12.1% |
| Return, 1 year | +614.4% | +18.6% |
| Avg daily volume | 20K | 4.5M |
| Holdings | 41 | 507 |
| Listed | Apr 4, 2019 | May 14, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS